drugset / Trial / NCT03471910

Clinical Non-inferiority Study Between Diosmin 600mg & Diosmin + Hesperidin in Symptomatic Chronic Venous Insufficiency

NCT03471910

Phase 4 Completed 120 enrolled Fundação Educacional Serra dos Órgãos
RandomizedParallel-groupTriple-blindTreatment

Summary

Clinical non-inferiority study between Diosmin 600 mg tablets and Diosmin 900 mg + Hesperidin 100 mg tablets in symptomatic chronic venous insufficiency after 6 months of treatment. Prospective, single-blind, randomized study in parallel groups (total patient population 120, 60 subjects per treatment group), with a total of 4 clinical assessment at months 0, 2, 4, and 6 of treatment.

Timeline

Start
2017-06-20
Primary completion
2018-03-20
Completion
2018-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Diosmin Small molecule 600 mg
Subject Diosmin Small molecule 900 mg
Comparator Hesperidin Small molecule 100 mg

Indications